LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 46 filers reported holding LYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $371,763 | +62.2% | 95,080 | +70.5% | 0.00% | – |
| Q2 2023 | $229,256 | +194.7% | 55,780 | +48.4% | 0.00% | – |
| Q1 2023 | $77,791 | -67.0% | 37,580 | -50.0% | 0.00% | – |
| Q4 2022 | $236,002 | +34.1% | 75,160 | +114.5% | 0.00% | – |
| Q3 2022 | $176,000 | -8.8% | 35,043 | +2.3% | 0.00% | – |
| Q2 2022 | $193,000 | -82.7% | 34,243 | -64.4% | 0.00% | – |
| Q1 2021 | $1,115,000 | +26.0% | 96,246 | +24.0% | 0.00% | – |
| Q4 2020 | $885,000 | +73.9% | 77,646 | +70.6% | 0.00% | – |
| Q3 2020 | $509,000 | +5.8% | 45,506 | +7.2% | 0.00% | – |
| Q2 2020 | $481,000 | – | 42,441 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,777,251 | $3,572,275 | 0.74% |
| Perceptive Advisors | 9,146,730 | $18,384,927 | 0.54% |
| PURA VIDA INVESTMENTS, LLC | 1,996,972 | $4,013,914 | 0.41% |
| VR Adviser, LLC | 924,170 | $1,857,582 | 0.36% |
| Nantahala Capital Management | 2,220,830 | $4,463,868 | 0.34% |
| Ikarian Capital, LLC | 343,685 | $711,427 | 0.16% |
| Soleus Capital Management, L.P. | 592,417 | $1,190,758 | 0.12% |
| Clearline Capital LP | 119,128 | $239,448 | 0.04% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 146,800 | $303,876 | 0.01% |
| Tower Research Capital LLC (TRC) | 9,972 | $20 | 0.00% |